StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)

Investment analysts at StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a report issued on Sunday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Price Performance

Enzo Biochem stock opened at $0.48 on Friday. Enzo Biochem has a twelve month low of $0.41 and a twelve month high of $1.30. The company’s 50-day moving average price is $0.55 and its two-hundred day moving average price is $0.86.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings results on Monday, March 17th. The medical research company reported ($0.02) earnings per share for the quarter. The company had revenue of $7.33 million during the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Virtu Financial LLC bought a new position in shares of Enzo Biochem during the fourth quarter worth approximately $35,000. Lepercq Multi Asset Fund bought a new position in shares of Enzo Biochem during the fourth quarter worth approximately $88,000. BBR Partners LLC bought a new position in shares of Enzo Biochem during the third quarter worth approximately $112,000. Wittenberg Investment Management Inc. increased its holdings in shares of Enzo Biochem by 60.1% during the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after purchasing an additional 70,400 shares during the period. Finally, Geode Capital Management LLC increased its holdings in shares of Enzo Biochem by 3.3% during the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after purchasing an additional 11,742 shares during the period. 36.90% of the stock is owned by institutional investors.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.